InvestSMART

Oncosil Medical Limited (ASX: OSL) - Announcements

Current share price for OSL : $1.150 0.05 (4.17%)+

ASX company news and announcements for Oncosil Medical Limited (OSL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Oncosil Medical Limited (OSL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Oncosil Medical Limited (OSL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Oncosil Medical Limited (OSL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$36 First two commercial patient treatments in Greece 8 Dec 2023 8:19AM $0.008 $1.150 risen by 14,275%
$36 Notification of cessation of securities - OSL 6 Dec 2023 10:50AM $0.009 $1.150 risen by 12,677.78%
$36 Final Director's Interest Notice BL 5 Dec 2023 4:32PM $0.009 $1.150 risen by 12,677.78%
$36 Results of Annual General Meeting 29 Nov 2023 1:06PM $0.008 $1.150 risen by 14,275%
$36 Presentation to Annual General Meeting 29 Nov 2023 9:25AM $0.008 $1.150 risen by 14,275%
$36 OncoSil onboards first patient in PANCOSIL Clinical Trial 29 Nov 2023 8:43AM $0.008 $1.150 risen by 14,275%
$36 OncoSil gaining traction in the Israeli healthcare market 24 Nov 2023 12:54PM $0.008 $1.150 risen by 14,275%
$36 Notice of Annual General Meeting/Proxy Form 31 Oct 2023 8:13AM $0.009 $1.150 risen by 12,677.78%
$36 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2023 2:49PM $0.009 $1.150 risen by 12,677.78%
$36 Date of AGM and Closing Date for Director Nominations 4 Oct 2023 3:30PM $0.010 $1.150 risen by 11,400%
$36 Mr Brian Leedman to retire from the Board of OncoSil 18 Sep 2023 4:56PM $0.011 $1.150 risen by 10,354.55%
$36 Notification of cessation of securities - OSL 13 Sep 2023 8:36AM $0.010 $1.150 risen by 11,400%
$36 Final Director's Interest Notice OB 31 Aug 2023 5:32PM $0.010 $1.150 risen by 11,400%
$36 Otto Buttula retires and Douglas Cubbin appointed Chair 31 Aug 2023 5:30PM $0.010 $1.150 risen by 11,400%
$36 Appendix 4G 31 Aug 2023 5:00PM $0.010 $1.150 risen by 11,400%
$36 Corporate Governance Statement 31 Aug 2023 4:59PM $0.010 $1.150 risen by 11,400%
$36 Appendix 4E and Annual Report 31 Aug 2023 4:56PM $0.010 $1.150 risen by 11,400%
$36 Change of principal place of business 16 Aug 2023 5:43PM $0.011 $1.150 risen by 10,354.55%
$36 Initial Director's Interest Notice 10 Aug 2023 8:59AM $0.011 $1.150 risen by 10,354.55%
$36 Douglas Cubbin appointed as Incoming Chairman of OncoSil 7 Aug 2023 8:38AM $0.013 $1.150 risen by 8,746.15%
$36 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2023 9:50AM $0.012 $1.150 risen by 9,483.33%
$36 Initial Director's Interest Notice GL 18 Jul 2023 12:24PM $0.012 $1.150 risen by 9,483.33%
$36 Gabriel Liberatore appointed to the Board of OncoSil 14 Jul 2023 4:33PM $0.013 $1.150 risen by 8,746.15%
$36 Change of Directors Interest Notice - Appendix 3Y OB 4 Jul 2023 10:15AM $0.012 $1.150 risen by 9,483.33%
$36 Multi-Centre Data on OncoSil in Metastatic Pancreatic Cancer 30 Jun 2023 9:49AM $0.012 $1.150 risen by 9,483.33%

301 - 325 of 794 results

Page 13 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.